Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Non-Coding RNA|December 22, 2022
The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate CancerLevi Groen, Viktor Yurevych, Harshitha Ramu, et al.
Clinical Genitourinary Cancer|October 15, 2022
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-AnalysisAino Siltari, Ragnar Lönnerbro, Karl Pang, et al.
The American Journal of Pathology|February 2, 2011
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancerPaula Vainio, Santosh Gupta, Kirsi Ketola, et al.
European Journal of Human Genetics : EJHG|August 12, 2010
Genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population: DG8S737 may not be the causative variantMaurice P Zeegers, Humera S Khan, Leo J Schouten, et al.
Cancers|September 28, 2021
Whole Blood Transcriptome Profiling Identifies DNA Replication and Cell Cycle Regulation as Early Marker of Response to Anti-PD-1 in Patients with Urothelial CancerSandra van Wilpe, Victoria Wosika, Laura Ciarloni, et al.
Molecular Oncology|March 2, 2021
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatmentEmmy Boerrigter, Guillemette E Benoist, Inge M van Oort, et al.
The Prostate|February 21, 2020
Validation of a 2-gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening populationJose Rubio-Briones, Angel Borque-Fernando, Luis M Esteban, et al.
Clinical Chemistry|May 15, 2020
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational StudyGuillemette E Benoist, Inge M van Oort, Emmy Boerrigter, et al.
Cancers|December 24, 2021
RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate CancerEmmy Boerrigter, Guillemette E Benoist, Inge M van Oort, et al.
BJU International|May 21, 2019
A four-group urine risk classifier for predicting outcomes in patients with prostate cancerShea P Connell, Marcelino Yazbek-Hanna, Frank McCarthy, et al.
Pageof 4